Equity Details
Price & Market Data
Price: $159.0
Daily Change: +$4.84 / 3.04%
Daily Range: $155.9 - $160.1
Market Cap: $10,968,060,928
Daily Volume: 1,340,877
Performance Metrics
1 Week: -5.48%
1 Month: -19.95%
3 Months: -37.26%
6 Months: -50.49%
1 Year: -50.00%
YTD: -44.29%
About Insulet Corporation (PODD)
Stay updated on Insulet Corporation (PODD). Price: 159.0, daily change: +$4.84 / 3.04%. Market cap: 10,968,060,928. Performance YTD, 1-week, and 52-week are key.
Company Details
Employees: 5400
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.